BPC-157

Overview

BPC-157, also known as Body Protection Compound 157, bepecin, or PL 14736, is a synthetic fifteen amino acid oligopeptide derived from a protein found in human gastric juice¹. The peptide was first discovered in 1992 during research on human gastric juice and has since been studied primarily in laboratory animals for its potential healing properties⁶. BPC-157 is promoted to protect organs from damage, speed up the healing and recovery of wounds in skin, tendon, muscle, ligament, and bone, and may also be marketed to enhance physical and mental performance, promote gut and joint health, or manage inflammation². The amino acid sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val¹.

Forms and Variations

BPC-157 is available in multiple forms for administration. The peptide demonstrates remarkable stability in human gastric juice, remaining intact for more than 24 hours, which supports its therapeutic effectiveness when administered orally¹. BPC-157 is stable at room temperature and bioavailable in rodent models when administered intramuscularly (IM) or intravenously (IV)¹. Some providers offer BPC-157 as an oral supplement, which eliminates the need to rely on compound pharmacies for injection formulations and provides significant cost savings compared to injectable versions³. Products containing BPC-157 might be labeled as "research chemicals" and carry statements such as "Not for human consumption," "Research use only," or "For research purposes only"².

Dosage and Administration

Specific dosage recommendations for BPC-157 in humans have not been established, as the peptide lacks FDA approval and clinical dosing guidelines. Research in animal models has utilized various concentrations, with some studies demonstrating effects at concentrations as low as 0.5 μg/mL⁴. The optimal dosage for human use remains unknown due to the limited clinical evidence available. Individuals considering BPC-157 should consult with a qualified healthcare professional to discuss appropriate dosing, administration routes, and potential risks. It is important to note that BPC-157 is not approved for human clinical use and should not be used without medical supervision⁷.

Scientific Research and Mechanism of Action

BPC-157 activates several molecular pathways that work together to promote tissue repair and healing. The peptide stimulates focal adhesion kinase (FAK)-paxillin complexes, which help cells migrate and attach to surfaces—crucial for wound healing because cells need to move into damaged areas and anchor themselves to begin rebuilding tissue¹. BPC-157 also stimulates JAK-2 (Janus kinase 2), a protein that relays signals from outside the cell to the nucleus where genes are activated, with this signaling pathway involved in cell survival, growth, and immune responses¹.

Research has revealed that growth hormone receptor is one of the most abundantly up-regulated genes in tendon fibroblasts by BPC-157, with the peptide dose- and time-dependently increasing the expression of growth hormone receptor at both the mRNA and protein levels⁴. At a concentration of 0.5 μg/mL, BPC-157 significantly induced the expression of growth hormone receptor in tendon fibroblasts time-dependently from day one to day three, with up to sevenfold increases observed at day three⁴.

BPC-157 modulates endothelial function by affecting Src and caveolin-1 (Cav-1) phosphorylation, which changes how VEGFR2 receptors are internalized into cells and how endothelial nitric oxide synthase (eNOS) is activated¹. The result is sustained production of nitric oxide, which keeps blood vessels dilated and ensures continuous blood flow to healing tissues¹. BPC-157 modulates cell growth, proliferation, survival, anti-inflammatory, and angiogenesis pathways⁶.

Benefits and Potential Uses

Preclinical studies demonstrate that BPC-157 has the potential to promote healing in various tissues. Research shows its potential for promoting healing in musculoskeletal injuries such as fractures, tendon ruptures, ligament tears, and muscle injuries⁶. A systematic review suggests that BPC-157 has the potential to reduce inflammation, promote vascularity, and augment structural, biomechanical, and functional recovery in fracture, muscle, tendon, and ligamentous injury models⁶.

Previous studies have demonstrated the promoting effect of BPC-157 on the healing of different tissues, including skin, mucosa, cornea, muscle, tendon, ligament and bone in animal studies⁶. BPC-157 can help ease inflammation, which is your body"s response to physiological stress and strain⁵. The peptide can enhance muscle development by helping build muscle more efficiently, enhancing the body"s natural healing abilities and creating new muscle tissue after weight-bearing exercise, while also aiding circulation so muscles receive more oxygenated blood and nutrients⁵. BPC-157 is also studied for its potential to promote gut and joint health, though human clinical evidence remains limited.

Side Effects and Risks

While no acute adverse events were reported in preclinical animal models over periods less than 6 weeks, clinical safety in humans remains unknown⁶. BPC-157 is not approved for human clinical use by the FDA and may lead to negative health effects⁷. The peptide could be added to the Prohibited List at any time, and its use is currently banned in professional sports⁷. Due to limited high-quality clinical evidence, clinicians and athletes should exercise caution when considering the use of BPC-157⁶. The long-term safety profile and potential adverse effects in humans have not been adequately studied.

Interactions and Precautions

Like other peptide hormones, BPC-157 is metabolized in the liver, excreted in the urine, and detectable for up to 4 days by mass spectrometry methods⁶. This metabolic profile suggests potential interactions with medications that affect liver function or renal excretion, though specific drug interactions have not been formally studied in humans. BPC-157 is listed in class S0: Non-Approved Substances on the World Anti-Doping Agency"s (WADA) Prohibited List and is also on the DoD Prohibited Dietary Supplement Ingredients List². Individuals in military service, professional athletes, or those subject to drug testing should be aware that BPC-157 use could result in positive test results. Pregnant women, nursing mothers, and individuals with liver or kidney disease should exercise particular caution and consult with healthcare professionals before considering BPC-157 use.

Impact on Biomarkers

BPC-157 influences several biomarkers related to tissue healing and growth. The peptide significantly increases growth hormone receptor expression in tendon fibroblasts, with up to sevenfold increases observed in laboratory studies⁴. BPC-157 affects markers of angiogenesis and vascular function through its modulation of endothelial nitric oxide synthase (eNOS) and sustained production of nitric oxide¹. The peptide also influences inflammatory markers through its anti-inflammatory pathways, though specific biomarker changes in human subjects have not been formally documented due to the lack of clinical trials.

Overdose and Toxicity

The safe upper limits and toxicity thresholds for BPC-157 in humans have not been established due to the absence of clinical trials and human safety data. Animal studies have not reported acute adverse events at the doses tested, but this does not guarantee safety in humans at any dose level⁶. The long-term effects of BPC-157 supplementation in humans remain unknown. Given the lack of established safety data, individuals should avoid self-dosing and should not exceed any recommendations provided by healthcare professionals. Any symptoms of adverse effects should be reported immediately to a qualified healthcare provider.

Disclaimer

The information provided in this document is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment. BPC-157 is not approved by the FDA for human use, and its safety and efficacy in humans have not been established through clinical trials.